To facilitate the rapid and precise detection of Acinetobacter baumannii, we present a protocol that employs Recombinase Polymerase Amplification (RPA) in conjunction with LbaCas12a endonuclease for identifying A. baumannii infections.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
To facilitate the rapid and precise detection of Acinetobacter baumannii, we present a protocol that employs Recombinase Polymerase Amplification (RPA) in conjunction with LbaCas12a endonuclease for identifying A. baumannii infections.
Acinetobacter baumannii, a gram-negative bacterium, is notorious for causing severe infections with high mortality rates. Rapid and accurate detection of A. baumannii is crucial for prompt treatment, effective infection control, and curbing antibiotic resistance. However, there is no suitable method for rapid and easy on-site detection of A. baumannii. The DNA Endonuclease Targeted CRISPR Trans Reporter (DETECTR) system offers a rapid, precise, and sensitive approach to A. baumannii detection by integrating the target-specific recognition capabilities of Cas12a with the isothermal amplification efficiency of Recombinase Polymerase Amplification (RPA). This protocol details the detection of A. baumannii using RPA combined with LbaCas12a endonuclease. The following steps are described in this article: extraction of DNA, selection of a specific DNA sequence, design of primer and CRISPR RNA (crRNA), construction of positive recombinant plasmid, setup of Cas12a-RPA assay, optimization of the RPA amplification system, visualization of the RPA-CRISPR/Cas12a assay using a fluorescence detection tool such as a real-time PCR instrument, and evaluation of sensitivity and specificity evaluation.
In clinical microbiology, detecting Acinetobacter baumannii infections presents a significant challenge. This gram-negative bacterium can cause infections with severe clinical symptoms, even with high mortality rates, particularly among immunocompromised patients1. Traditional culture-based detection methods for pathogen infections are time-consuming and may lack sensitivity, which may delay antibiotic treatment and compromise patient outcomes. Rapid and accurate identification of A. baumannii is crucial for effective treatment and outbreak control. Molecular techniques employing nucleic acid amplification have been explored t....
Access restricted. Please log in or start a trial to view this content.
1. Construction of the A. baumannii -DETECTR
NOTE: The construction of A. baumannii-DETECTR is a four-step process involving the design of primer and crRNA, the construction of positive recombinant plasmid construction, the preparation of reaction solutions, isothermal DNA amplification by RPA, and the visualization of the RPA-CRISPR/Cas12a assay. The schematic of the DETECTR assay is illustrated in Figure 1.
Access restricted. Please log in or start a trial to view this content.
In this study, we introduce a novel, portable diagnostic platform named A. baumannii-DETECTR, which integrates the isothermal amplification efficiency of RPA and CRISPR-Cas12a system for rapid and reliable field identification of A. baumannii. The schematic of the DETECTR assay is illustrated in Figure 1.
Twelve pairs of primers were designed using design toolson the basis of prime.......
Access restricted. Please log in or start a trial to view this content.
Traditional diagnostic methods for A. baumannii infections have various restrictions that make them less accessible and feasible for point-of-care testing27. For example, PCR has good sensitivity and specificity but necessitates specialized thermal cycling equipment and complex workflows that must be operated by professionals. The novel method presented here, which couples RPA and CRISPR-LbaCas12a genome editing with recombineering, known as the A. baumannii-DETECTR assay, allows.......
Access restricted. Please log in or start a trial to view this content.
The authors declare that they have no competing interests.
This work was supported by Science and Technology Development Plan Project of Jilin Province, China (20240305027YY) and Jilin Provincial Department of Finance (JLSWSRCZX2023-55, JLSWSRCZX2021-041).
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| -20 °C Freezer | Haier | HYCD-290 | China |
| Agarose Basic | BioFroxx | 1110GR100 | China |
| All oligonucleotides and crRNA were synthesized by company | www.comatebio.com | ||
| Cas12a cutting substrate - ssDNA - fluorescent type | EZassay Biotech. Co. Ltd. | DNA-FAM-BHQ | China |
| Cas12a cutting substrate - ssDNA - test paper type | EZassay Biotech. Co. Ltd. | DNA-FAM-BIO | China |
| Electrophoresis apparatus | BIO-RAD | POWER PAC1000 | USA |
| Fluorescence quantitative PCR instrument | BIO-RAD | CFX Connect | USA |
| Gel Imaging System | BIO-RAD | Gel Doc 2000 | USA |
| https://ezassay.com/rna | |||
| https://www.ezassay.com/primer | |||
| https://www.ncbi.nlm.nih.gov/tools/primer-blast | |||
| Lateral flow paper strip (Biotin/FAM) | EZassay Biotech. Co. Ltd. | HD-FMBO | China |
| LbaCas12a (Cpf1) enhanced protein | EZassay Biotech. Co. Ltd. | CAS-12E-001 | China |
| LED Transilluminator | LABGIC | BL-20 | China |
| Magnesium acetate, MgOAc | TwistDx | TABAS03KIT | UK |
| Microcentrifuge | allsheng | Mini-6k | China |
| PCR strip tubes | PCR strip tubes | PST-0208-FT-C | China |
| TGrade Dry Bath Incubator | Tiangen biochemical technology | OSE-DB-01 | China |
| Tianamp Bacteria DNA Kit | Tiangen biochemical technology | DP302-02 | China |
| TIANamp Bacteria DNA Kit | TIANGEN BIOTECH (BEIJING) CO.; LTD. | DP302 | China |
| TransStart FastPfu DNA Polymerase | TransGen Biotech. Co. Ltd. | AP221 | China |
| TwistAmp Basic Kit | TwistDX | TABAS03KIT | UK |
| Universal DNA Purification Kit | Tiangen biochemical technology | DP214-03 | China |
Access restricted. Please log in or start a trial to view this content.